BLRX

BioLineRX
BLRX

14 hedge funds and large institutions have $136K invested in BioLineRX in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less call options, than puts

Call options by funds: $33K | Put options by funds: $34K

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33K
Puts
$34K
Net Calls
Net Calls Change

Top Buyers

1
+$92K
2
+$7.04K
3
+$5.18K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$978
5
Osaic Holdings
Osaic Holdings
Arizona
+$86

Top Sellers

1
-$20.2K
2
-$15.3K
3
-$147
4
SS
SBI Securities
Japan
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$104K
RhumbLine Advisers
2
RhumbLine Advisers
Massachusetts
$9.55K
Citigroup
3
Citigroup
New York
$5.81K
UBS Group
4
UBS Group
Switzerland
$5.4K
Wells Fargo
5
Wells Fargo
California
$4.85K
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$4.16K
NRG
7
Nemes Rush Group
Michigan
$693
NA
8
NewEdge Advisors
Louisiana
$296
Morgan Stanley
9
Morgan Stanley
New York
$277
Osaic Holdings
10
Osaic Holdings
Arizona
$71
Rockefeller Capital Management
11
Rockefeller Capital Management
New York
$33
Bank of America
12
Bank of America
North Carolina
$28
DB
13
Danske Bank
Denmark
$6
TRCT
14
Tower Research Capital (TRC)
New York
–
SS
15
SBI Securities
Japan
–
BCV
16
Banque Cantonale Vaudoise
Switzerland
–